Drug Database
EL

elastase (elastase / Elaszym)

✓ Approved

Eisai Co., Ltd. · 治疗药物

什么是 elastase?

elastase 是一种治疗药物,由Eisai Co., Ltd.研发。该药已获批,用于治疗相关适应症。

药物档案

商品名elastase, Elaszym
公司Eisai Co., Ltd.
状态Approved

治疗适应症

elastase 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Vascular disordersArteriosclerosis✓ Approved

相关研究文献

PubMedPlant foods for human nutrition (Dordrecht, Netherlands)2026-11-19

Harnessing the Antibacterial Potential of Star Fruit Extract against MRSA: Metabolic Profiling, Molecular Docking, and In Vitro Wound-Healing Effects.

Eraqi Walaa A WA, Mohamed Sally A SA, Hanafi Maha M, Salem Mohamed A MA et al.

Averrhoa carambola L. (star fruit) is recognized for its nutritional value and bioactive constituents. This study investigated its antibacterial and antibiofilm activities against methicillin-resistant Staphylococcus aureus (MRSA) and its potential to promote wound healing. The in vitro antibacterial activity of the extract was evaluated against six MRSA strains by determining the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and time-kill kinetics. The extract exhibited a uniform MIC of 1.95 mg/mL against all tested MRSA strains, while MBC values ranged from 15.6 to 125 mg/mL. Biofilm inhibition was assessed using a crystal violet assay, while transmission electron microscopy and intracellular ion leakage analysis were used to investigate the antibacterial mechanism. The extract significantly inhibited biofilm formation at 0.5 × and 0.25 × MIC, particularly against MS3 and MS15 strains (p ≤ 0.05). The extract induced membrane damage and significant leakage of intracellular phosphate (p = 0.0036) and potassium (p = 0.0001). Its cytocompatibility and wound-healing activity were evaluated using primary human adult dermal fibroblasts (HDFa) and an in vitro scratch assay. The extract showed an EC50 of 2.96 mg/mL without reducing HDFa viability and significantly enhanced wound closure to 70%, compared with 82% for dexamethasone. UPLC-QTOF-MS/MS profiling identified 130 metabolites, with flavonoids representing the predominant class (49 compounds). Molecular docking further predicted favorable binding interactions between selected flavonoids and collagenase, elastase, and lipase. These findings demonstrate the antibacterial, antibiofilm, and in vitro wound-healing potential of star fruit extract against MRSA.

PMID 43052601
阅读全文 →
PubMedNano letters2026-11-18

Atomically Precise Au14V1 Clusters Selectively Block the Neutrophil Elastase-NETosis Axis.

Zhou Sufei S, Wang Yili Y, Li Guo G, Yu Hongli H et al.

Neutrophil elastase (NE) is a key driver of neutrophil-mediated inflammation and tissue injury across diverse diseases. However, current NE inhibitors often lack sufficient target selectivity, limiting their therapeutic efficacy in suppressing inflammation and promoting organ repair. Here, we report that single-atom V doping programs atomically precise Au15 clusters into a relatively selective and potent NE inhibitor. The ultrasmall size of Au14V1 enables selective accommodation within the NE binding pocket. Multiscale mechanistic analyses demonstrated that Au14V1 inhibits NE through a reversible mixed inhibition mechanism with an inhibition rate of 87.6%, while exhibiting minimal activity toward closely related proteases, highlighting its preferential inhibition toward NE. In LPS- and CLP-induced systemic inflammatory injury models, Au14V1 reduced NE activity and NET formation, alleviated oxidative stress and inflammatory responses, mitigated tissue injury, and improved survival. These findings establish a single-atom engineering strategy for developing selective enzyme modulators and precise therapy targeting the NE-NETosis axis.

PMID 43049661
阅读全文 →
PubMedAdvanced healthcare materials2026-11-18

A Stearyl-Peptide Based Versatile Strategy to Design Enzyme-Responsive Liposomes for Targeted Drug Delivery.

Raghunathan Shruti S, Luc Norman N, Disharoon Dante D, Rohiwal Sonali S et al.

Liposomes are a prominent class of drug delivery nanoparticles. For currently approved liposomal therapeutics, drug is released predominantly via diffusion which has spatio-temporal kinetic and bioavailability challenges, especially in a dynamic environment. Next-generation liposome designs focus on stimuli-triggered enhancement of drug release. One exciting approach here is liposomes that can be site-specifically destabilized by disease-associated enzymes. Feasibility of this has been demonstrated with certain phospholipases or metalloproteases, but a versatile strategy for designing liposomes triggerable by any disease-specific enzyme remains lacking. We report a unique liposome design using enzyme-cleavable stearyl-peptide conjugates. Stearylamine has been explored for cationic liposomes in gene delivery, but the cationic charge poses significant cytotoxicity. We demonstrate that conjugating enzyme-cleavable peptides to stearylamine and assembly of stearyl-peptide conjugates within liposomes mitigates the cationic charge and significantly enhances biosafety. Surface-decorating such liposomes with target-specific ligands enables their active target-anchorage under flow. Exposure of target-anchored liposomes to disease-relevant enzymes renders stearyl-peptide cleavage and liposome destablization, enhancing drug release. We demonstrate the design versatility utilizing microfluidic models of three different vascular pathologies (hyperfibrinolysis, thrombosis and thromboinflammation) and delivering three corresponding drugs (tranexamic acid, tissue plasminogen activator and deoxyribonulease) triggered by three different enzymes (plasmin, thrombin and neutrophil elastase), respectively.

PMID 43046117
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Naringenin as a Multifunctional Ingredient Targeting Pathways Associated With Skin Inflammaging: Preclinical and Clinical Evidence.

Oswald Taylor T, Shao Zixuan Z, Brideau Nicholas N

Inflammaging, a sustained state of low-level inflammatory activity with age, is a driving factor in age-related changes in skin structure, function, and appearance. By perturbing fundamental biological pathways, inflammaging is a relevant target in skincare and anti-aging research. The objective of this study was to investigate the anti-inflammatory and anti-aging potential of naringenin, a natural flavonoid, using a combination of mechanistic in vitro analyses and a controlled human clinical evaluation. The activities and mechanism of action of naringenin were tested on normal human epidermal keratinocytes and in complementary acellular assays. A placebo-controlled clinical study was conducted to assess the effects of topical naringenin on multiple skin parameters. Transcriptomic analysis was applied as a discovery-driven strategy to characterize the molecular responses induced by naringenin. Naringenin was found to have anti-inflammatory properties, including downregulation of proinflammatory pathway genes, a significant reduction in biomarkers interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in keratinocytes, and a reduction in visible redness in clinical trial participants. In addition to its anti-inflammatory activity, naringenin exhibited a multimodal anti-aging profile, including gene expression changes consistent with modulation of skin aging, radical-scavenging capacity, inhibition of elastase activity, and reduced protein glycation. Topical application led to statistically significant improvements in multiple skin attributes. These findings identify naringenin as a multifunctional bioactive ingredient with anti-inflammaging properties relevant to skincare. The anti-inflammaging function of naringenin is further supported by clinical outcomes showing improved wrinkle appearance, skin elasticity, and hydration following topical use.

PMID 43047200
阅读全文 →
PubMedJournal of cosmetic dermatology2026-11-18

Identification of A Novel Antioxidant Tripeptide Ameliorating Skin Photoaging.

Lu Jianghua J, Li Jie J, Wang Liang L, Xia Liming L et al.

Skin photodamage induced by ultraviolet (UV) exposure is the primary factor of photoaging, and developing bioactive molecules targeting this process represents a key focus in dermatology and cosmetic biotechnology. However, a comprehensive screening strategy combining combinatorial library construction with multi-target validation has not yet been fully established. To establish a systematic screening strategy for bioactive peptide molecules and to assess the antioxidant, anti-photoaging effects of the identified bioactive peptide on skin cells. In this study, 17 out of 20 common amino acids were chosen according to their antioxidant capacity via H2O2- and UVB-induced oxidative stress models. Based on these 17 amino acids, a tripeptide library containing 4913 molecules was constructed using a full combinatorial strategy. With skin melanin synthesis (tyrosinase), extracellular matrix degradation (elastase or hyaluronidase), and oxidative stress regulation (Keap1) as core targets, 10 potential bioactive tripeptides were screened out through molecular docking technology. Subsequently, mitochondrial function was examined by detecting mitochondrial membrane potential and mitochondrial superoxide anion levels to evaluate the antioxidant activity of the identified tripeptide. Detection of mRNA levels of antioxidant-related genes and RNA-seq analysis were performed to investigate the associated signaling pathways. Additionally, senescence-associated β-galactosidase staining was used to assess the anti-aging capacity. In vitro functional validation confirmed that tripeptide FAW exhibited the optimal performance in migration capacity and antioxidant activity for skin cells. Mechanistic studies revealed that FAW may enhance cellular antioxidant capacity by activating the NRF2/HMOX-1 pathway and regulate skin aging-related signaling pathways. The results showed that FAW could alleviated UV-induced skin cell damage and photoaging, and ameliorate passage number-induced replicative senescence. This study established a screening strategy for bioactive peptide molecules, encompassing amino acid screening, tripeptide library construction, multi-target molecular docking, and functional validation. Notably, tripeptide FAW identified in this study showed promising application potential for skincare.

PMID 43046983
阅读全文 →
PubMedMedical oncology (Northwood, London, England)2026-11-18

PES1 promotes hepatocellular carcinoma growth by triggering CDK7/MDK-dependent neutrophil extracellular trap formation.

Yi Nan N, Zhang Lingyun L, Zeng Shuangshuang S, Ma Jilei J et al.

Hepatocellular carcinoma (HCC) is characterized by a high recurrence rate and poor prognosis, requiring the identification of novel molecular drivers within the tumor-immune microenvironment. In this study, by performing a targeted prognostic prioritization of the HCC transcriptome via median survival and hazard ratio modeling, pescadillo ribosomal biogenesis factor 1 (PES1) was identified as a key prognostic driver, validated through survival intervals and tissue expression. While PES1 is a known component of the PeBoW complex involved in cell cycle regulation, its role in modulating the HCC immune microenvironment remains undefined. Netx, we performed a secondary screening across various leukocyte lineages using conditioned medium from PES1-overexpressing HCC cells. This functional screening revealed that PES1 specifically triggers the expression of elastase, a key functional component of neutrophil extracellular traps (NETs), with predominant effects on neutrophils. Driven by this targeted induction of a NET-associated marker, we subsequently quantified MPO-DNA complexes and confirmed that PES1 indeed promotes the formation of NETs. In vivo, the PES1-driven acceleration of tumor growth was effectively abrogated by degradation of NET-DNA using DNase I, demonstrating that PES1-mediated malignancy is NET-dependent. Mechanistically, we identified midkine (MDK) as the primary effector significantly upregulated and secreted by PES1-overexpressing HCC cells. Neutralization of MDK signaling via iMDK effectively abolished PES1-induced NET formation. Furthermore, we demonstrated that CDK7 suppression inhibited PES1-driven MDK upregulation. This dependency was further validated that THZ1-mediated inhibition of CDK7 effectively abolished both MDK secretion and subsequent NET formation. This PES1/CDK7/MDK axis triggers NET formation by activating peptidylarginine deiminase 4 (PAD4), a process that could be targeted via pharmacological inhibition of PAD4 to suppress the pro-tumorigenic niche. Taken together, these findings identify the PES1/CDK7/MDK/PAD4 axis as a critical driver of NET-mediated HCC progression, underscoring the potential value of PES1 as a prognostic biomarker and a therapeutic target in HCC.

PMID 43050009
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多elastase